Drug profile · INN
pyridostigmine
MESTINON
pyridostigmine (MESTINON) is a acetylcholinesterase inhibitor. Associated with Lacuna Pharma Pty Ltd.
Drug details — pyridostigmine
- Class
- —
- Route
- —
- Patents
- 5
- Programs
- 0
- Data quality
- 0.81
Quick answer
pyridostigmine (MESTINON) is a acetylcholinesterase inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
Mechanism of action
Acetylcholinesterase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related patents
-
US 12233166
Extended release compositions comprising pyridostigmine
granted -
US 11911515
Extended release compositions comprising pyridostigmine
granted -
US 11666536
Extended release compositions comprising pyridostigmine
granted -
US 11478425
Extended release compositions comprising pyridostigmine
granted -
US 11229606
Extended release compositions comprising pyridostigmine
granted
Frequently asked questions
What is pyridostigmine?
pyridostigmine (MESTINON) is a acetylcholinesterase inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for pyridostigmine?
MESTINON is a marketed brand name for pyridostigmine. Check FDA Drugs@FDA for the current US label holder and prescribing information.